Branded Products
Mounjaro
Experience Mounjaro® (tirzepatide) delivered through a once-weekly injectable treatment designed to support metabolic health and medical weight management within a provider-directed program, helping regulate appetite and blood sugar response through a dual-hormone mechanism aligned with individualized care plans and ongoing medical evaluation when prescribed.
Treatment Details
| Medicine Detail | Information |
|---|---|
| Medication Type | Dual GIP and GLP-1 receptor agonist |
| Form | Subcutaneous injectable prescription medication |
| Dosing Schedule | Administered once weekly as provider directed |
| Usage Category | Metabolic health and medical weight management treatment option |
Ozempic
Experience Ozempic® (semaglutide) delivered through a once-weekly injectable treatment designed to support metabolic health and medical weight management as part of a provider-directed program, helping regulate blood sugar levels and appetite control through a clinically guided approach aligned with individualized care plans and ongoing medical evaluation when prescribed.
Treatment Details
| Medicine Detail | Information |
|---|---|
| Medication Type | GLP-1 receptor agonist |
| Form | Subcutaneous injectable prescription medication |
| Dosing Schedule | Administered once weekly as provider directed |
| Usage Category | Metabolic health and medical weight management treatment option |
Wegovy
Experience Wegovy® (semaglutide) delivered through a once-weekly injectable treatment designed to support medical weight management as part of a provider-directed program, helping regulate appetite and promote structured weight loss through a clinically guided approach aligned with individualized care plans and ongoing medical evaluation when prescribed.
Treatment Details
| Medicine Detail | Information |
|---|---|
| Medication Type | GLP-1 receptor agonist |
| Form | Subcutaneous injectable prescription medication |
| Dosing Schedule | Administered once weekly as provider directed |
| Usage Category | Medical weight management treatment option |
Zepbound
Experience Zepbound® (tirzepatide) delivered through a once-weekly injectable treatment designed to support medical weight management within a provider-directed program, helping regulate appetite and improve metabolic response through a dual-hormone approach aligned with individualized care plans and ongoing medical evaluation when prescribed.
Treatment Details
| Medicine Detail | Information |
|---|---|
| Medication Type | Dual GIP and GLP-1 receptor agonist |
| Form | Subcutaneous injectable prescription medication |
| Dosing Schedule | Administered once weekly as provider directed |
| Usage Category | Medical weight management treatment option |